Andarine as a Stack-Ready SARM Anchor
Andarine (S-4) is a non-steroidal, orally bioavailable SARM that binds selectively to androgen receptors in skeletal muscle and bone, making it a stackable compound suited for both calorie-restricted cutting protocols and calorie-surplus bulking phases. Unlike anabolic steroids, Andarine produces tissue-selective anabolic signalling without triggering the full androgenic cascade. Vital Research supplies Andarine at 25 mg per tablet — giving athletes the flexibility to halve, maintain, or escalate dose depending on stack companions and cycle goals.
Cutting Stack: Andarine + Ostarine + Cardarine
The classic cutting trio pairs Andarine with Ostarine (MK-2866) and Cardarine (GW-501516). Andarine drives muscular density and a firm, striated appearance during a caloric deficit. Ostarine preserves lean tissue when dietary protein targets are met, while Cardarine activates PPAR-δ pathways to enhance fat oxidation — confirmed in preclinical pharmacology studies. Compared to running Andarine alone, this triple combination addresses three distinct mechanisms — androgen receptor activation, muscle preservation, and lipid metabolism — simultaneously. Typical cutting stacks run 6–8 weeks at 25 mg Andarine daily.
Bulking Stack: Andarine + LGD-4033 + RAD-140
For mass-accumulation phases, Andarine stacks with LGD-4033 (Ligandrol) and RAD-140 (Testolone) to create a potent anabolic environment without injectable compounds. LGD-4033 binds androgen receptors with high affinity (Ki ~1 nM, reported in Ligand Pharmaceuticals preclinical data), RAD-140 provides strong muscle-protein synthesis stimulation, and Andarine contributes additional receptor occupancy and connective-tissue support. This triple stack typically runs 8 weeks, with Andarine dosed at 25 mg daily. Vital Research's HPLC-verified tablets ensure each 25 mg dose is accurate to ±2 % — critical when stacking multiple compounds where cumulative receptor load matters.
Quality Assurance at Vital Research
Vital Research subjects every Andarine production batch to third-party HPLC chromatography for active-compound quantification and LAL (Limulus Amebocyte Lysate) testing for bacterial endotoxin detection. GMP-grade raw materials are sourced and traceable; certificates of analysis are retained per batch. These quality controls ensure the 25 mg dose printed on the label reflects actual tablet content — a non-negotiable standard when stacking SARMs where dosing precision determines both efficacy and safety margin.